- Home
- ATNM vs FLNT Comparison
ATNM vs FLNT Comparison
Compare ATNM & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- FLNT
- Stock Information
- Founded
- ATNM 2000
- FLNT 2001
- Country
- ATNM United States
- FLNT United States
- Employees
- ATNM N/A
- FLNT N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- FLNT Advertising
- Sector
- ATNM Health Care
- FLNT Consumer Discretionary
- Exchange
- ATNM Nasdaq
- FLNT Nasdaq
- Market Cap
- ATNM 51.5M
- FLNT 45.7M
- IPO Year
- ATNM N/A
- FLNT N/A
- Fundamental
- Price
- ATNM $1.68
- FLNT $1.90
- Analyst Decision
- ATNM Strong Buy
- FLNT Hold
- Analyst Count
- ATNM 3
- FLNT 1
- Target Price
- ATNM $4.67
- FLNT $3.00
- AVG Volume (30 Days)
- ATNM 221.4K
- FLNT 30.5K
- Earning Date
- ATNM 05-09-2025
- FLNT 05-15-2025
- Dividend Yield
- ATNM N/A
- FLNT N/A
- EPS Growth
- ATNM N/A
- FLNT N/A
- EPS
- ATNM N/A
- FLNT N/A
- Revenue
- ATNM N/A
- FLNT $243,850,000.00
- Revenue This Year
- ATNM N/A
- FLNT $9.20
- Revenue Next Year
- ATNM N/A
- FLNT $8.67
- P/E Ratio
- ATNM N/A
- FLNT N/A
- Revenue Growth
- ATNM N/A
- FLNT N/A
- 52 Week Low
- ATNM $1.03
- FLNT $1.50
- 52 Week High
- ATNM $8.64
- FLNT $3.83
- Technical
- Relative Strength Index (RSI)
- ATNM 57.88
- FLNT 42.63
- Support Level
- ATNM $1.51
- FLNT $1.75
- Resistance Level
- ATNM $1.69
- FLNT $1.85
- Average True Range (ATR)
- ATNM 0.11
- FLNT 0.20
- MACD
- ATNM -0.01
- FLNT -0.02
- Stochastic Oscillator
- ATNM 64.37
- FLNT 33.61
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.